Biotechnology: the key points at a glance

Biotechnology: the key points at a glance
Culture cellulaire 3D de InSphero AG

Switzerland is one of the strongest biotechnology hubs in Europe. Significant innovations and the close cooperation between research and development form the basis for the success of more than 250 biotechnology companies located here. Top-class research institutions, leading SMEs, and strong multinational corporations form a network that ensures healthy growth and that attracts researchers and capital from around the entire world. 

This is evident in the constantly increasing number of biotechnology patents in Switzerland. Back in 2010, 1.5 patents for every 100,000 inhabitants had been filed and this number has increased to two, according to an OECD survey conducted in 2012. Switzerland is therefore in second place in a comparison of OECD countries – Denmark leads with 2.8 biotechnology patents for every 100,000 inhabitants and Israel follows with 1.3 biotechnology patents for every 100,000 inhabitants.

As an important European Life Sciences stock exchange with a trading volume of 350 billion euros, Switzerland offers an outstanding framework for procuring capital. The SIX Swiss Exchange invests 40% of its traded capital in Life Sciences projects. The economic and scientific environment boasts the presence of successful international chemical and pharmaceutical companies, such as Novartis and Roche, as well as innovative firms from the medical technology, biotechnology, and nanotechnology sectors. Making it highly suitable for strategic partnerships, licensing, or patent sales. Modern infrastructure, high quality of life, and access to excellently trained employees supplement the extremely positive conditions for a strong and future-oriented biotechnology industry in Switzerland.

Download the biotechnology fact sheet

Global,

Switzerland is one of the strongest biotechnology hubs in Europe. Significant innovations and the close cooperation between research and development form the basis for the success of more than 250 biotechnology companies located here. Top-class research institutions, leading SMEs, and strong multinational corporations form a network that ensures healthy growth and that attracts researchers and capital from around the entire world. 

This is evident in the constantly increasing number of biotechnology patents in Switzerland. Back in 2010, 1.5 patents for every 100,000 inhabitants had been filed and this number has increased to two, according to an OECD survey conducted in 2012. Switzerland is therefore in second place in a comparison of OECD countries – Denmark leads with 2.8 biotechnology patents for every 100,000 inhabitants and Israel follows with 1.3 biotechnology patents for every 100,000 inhabitants.

As an important European Life Sciences stock exchange with a trading volume of 350 billion euros, Switzerland offers an outstanding framework for procuring capital. The SIX Swiss Exchange invests 40% of its traded capital in Life Sciences projects. The economic and scientific environment boasts the presence of successful international chemical and pharmaceutical companies, such as Novartis and Roche, as well as innovative firms from the medical technology, biotechnology, and nanotechnology sectors. Making it highly suitable for strategic partnerships, licensing, or patent sales. Modern infrastructure, high quality of life, and access to excellently trained employees supplement the extremely positive conditions for a strong and future-oriented biotechnology industry in Switzerland.

Download the biotechnology fact sheet

Downloads 
Page Meta 
Fact Sheet
  • Swiss Business Hub India
    Head of Swiss Business Hub India
    502 Dalamal House, 5th Floor, 206, Jamnalal Bajaj Marg, Nariman Point, Mumbai
    +91 22 4343 56 00
  • Swiss Business Hub India
    Senior Investment Advisor
    502 Dalamal House, 5th Floor, 206, Jamnalal Bajaj Marg, Nariman Point, Mumbai
    +91 22 4343 56 00

Explore Leading Companies - Biotech